Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspective. Issue 1 (24th December 2020)

• Record Type: Journal Article
• Authors: Schumacher, Lauren; Leino, Abbie D.; Park, Jeong M.
• Other Names: Doligalski Christina Teeter guestEditor.; Bowman Lyndsey J. guestEditor.
• Is Part Of: Pharmacotherapy. Volume 41:Issue 1(2021)
• Page Start: 103
• Page End: 118
• Publication Date: 2020-12-24
• Subjects: coefficient of variation -- intrapatient variability -- outcomes -- solid organ transplantation -- standard deviation -- tacrolimus -- therapeutic drug monitoring -- time in therapeutic range; Chemotherapy -- Periodicals; Pharmacology -- Periodicals; Drug Therapy -- Periodicals; Pharmacology -- Periodicals; 615.1
• DOI: 10.1002/phar.2480
• Languages: English
• ISSNs: 0277-0008

Abstract

Abstract: B ackground: Tacrolimus therapy in solid organ transplant (SOT) recipients is challenging due to its narrow therapeutic window and pharmacokinetic variability both between patients and within a single patient. Intrapatient variability (IPV) of tacrolimus trough concentrations has become a novel marker of interest for predicting transplant outcomes. The purpose of this review is to evaluate the association of tacrolimus IPV with graft and patient outcomes and identify interventions to improve IPV in SOT recipients. M ethods: A systematic review of the literature was performed using PubMed and Embase from database inception to September 20, 2020. Studies were eligible only if they evaluated an association between tacrolimus IPV and transplant outcomes. Both pediatric and adult studies were included. Measures of variability were limited to standard deviation, coefficient of variation, and time in therapeutic range. R esults: Forty‐four studies met the inclusion criteria. Studies were published between 2008 and 2020 and were observational in nature. Majority of data were published in adult kidney transplant recipients and identified an association with rejection, de novo donor specific antibody (dnDSA) formation, graft loss, and patient survival. Evaluation of IPV‐directed interventions was limited to small preliminary studies. C onclusions: High tacrolimus IPV has been associated with poor outcomes including acute rejection, dnDSA formation, graft loss, and patient mortality in SOT recipients. Future research should prospectively explore IPV‐directed interventions to improve transplant outcomes.